v3.25.2
Reportable Segments - Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Segment Reporting Information [Line Items]          
Research, development and engineering expenses $ 276 $ 262 $ 546 $ 520  
Depreciation     603 614  
Income tax provision (benefit) 84 50 139 121  
Segment net income (loss) $ 469 $ 104 $ 626 $ 313  
Effective tax rate (as a percent) 21.00% 21.00% 21.00% 21.00%  
Operating Segments          
Segment Reporting Information [Line Items]          
Segment net sales $ 4,045 $ 3,604 $ 7,724 $ 6,862  
Research, development and engineering expenses 233 222 469 438  
Depreciation 310 305 599 610  
Other segment items 2,662 2,370 5,071 4,529  
Income tax provision (benefit) 182 152 344 277  
Segment net income (loss) 658 555 1,241 1,008  
Investment in affiliated companies, at equity 309   309   $ 290
Segment assets 18,782   18,782   17,626
Capital expenditures 323 213 562 399  
Optical Communications | Operating Segments          
Segment Reporting Information [Line Items]          
Segment net sales 1,566 1,113 2,921 2,043  
Research, development and engineering expenses 76 66 153 131  
Depreciation 69 66 134 132  
Other segment items 1,102 797 2,056 1,468  
Income tax provision (benefit) 72 41 130 69  
Segment net income (loss) 247 143 448 243  
Investment in affiliated companies, at equity 6   6   4
Segment assets 3,952   3,952   3,506
Capital expenditures 87 48 184 84  
Display | Operating Segments          
Segment Reporting Information [Line Items]          
Segment net sales 898 1,014 1,803 1,886  
Research, development and engineering expenses 24 28 49 54  
Depreciation 108 110 210 226  
Other segment items 460 550 931 1,026  
Income tax provision (benefit) 63 68 127 121  
Segment net income (loss) 243 258 486 459  
Investment in affiliated companies, at equity 101   101   90
Segment assets 6,773   6,773   6,596
Capital expenditures 65 61 111 134  
Specialty Materials | Operating Segments          
Segment Reporting Information [Line Items]          
Segment net sales 545 501 1,046 955  
Research, development and engineering expenses 68 57 135 117  
Depreciation 39 40 74 76  
Other segment items 335 324 640 627  
Income tax provision (benefit) 22 17 42 28  
Segment net income (loss) 81 63 155 107  
Investment in affiliated companies, at equity 18   18   15
Segment assets 2,648   2,648   2,489
Capital expenditures 45 27 76 60  
Automotive | Operating Segments          
Segment Reporting Information [Line Items]          
Segment net sales 460 479 900 970  
Research, development and engineering expenses 35 41 70 79  
Depreciation 41 44 82 87  
Other segment items 284 304 562 615  
Income tax provision (benefit) 21 19 39 40  
Segment net income (loss) 79 71 147 149  
Investment in affiliated companies, at equity    
Segment assets 2,439   2,439   2,366
Capital expenditures 30 12 42 21  
Life Sciences | Operating Segments          
Segment Reporting Information [Line Items]          
Segment net sales 250 249 484 485  
Research, development and engineering expenses 7 6 13 12  
Depreciation 15 17 31 34  
Other segment items 206 205 401 401  
Income tax provision (benefit) 4 4 8 8  
Segment net income (loss) 18 17 31 30  
Investment in affiliated companies, at equity    
Segment assets 827   827   800
Capital expenditures 3 3 6 8  
Hemlock and Emerging Growth Businesses | Operating Segments          
Segment Reporting Information [Line Items]          
Segment net sales 326 248 570 523  
Research, development and engineering expenses 23 24 49 45  
Depreciation 38 28 68 55  
Other segment items 275 190 481 392  
Income tax provision (benefit) 3 (2) 11  
Segment net income (loss) (10) 3 (26) 20  
Investment in affiliated companies, at equity 184   184   181
Segment assets 2,143   2,143   $ 1,869
Capital expenditures $ 93 $ 62 $ 143 $ 92